---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-24-000056"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:22:54.714824+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nika Pharmaceuticals acquires subsidiary and factory building valued at $2.05M; signs $958K supply agreement

## Summary
- Acquired 100% of Nika Pharmaceuticals, Ltd. from CEO Dimitar Savov for nominal 5,000 BGN (~$2,800).
- Acquisition includes beneficial ownership of a production building and land in Sofia valued at $2,045,209.
- Nika Europe, Ltd. signed a GMP vial production line supply agreement with Shanghai Marya for $957,670; down payment of $191,534 paid by CEO personally.
- Equipment delivery and installation expected by end of Q4 2024.

## SEC filing metadata
- accession: 0001826466-24-000056
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000056/0001826466-24-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000056/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-24-000056
- JSON: https://secwatch.observer/filing/0001826466-24-000056.json
- Plain text: https://secwatch.observer/filing/0001826466-24-000056.txt

## Key facts
- M&A Transactions
  NIKA PHARMACEUTICALS, INC completed an acquisition involving Dimitar Slavchev Savov for nominal value of the capital of the company, 5,000 BGN (closed 2024-05-09).
  - Action: acquisition
  - Counterparty: Dimitar Slavchev Savov
  - Consideration: nominal value of the capital of the company, 5,000 BGN
  - Closing: 2024-05-09
  source text: Effective May 9, 2024, Nika Pharmaceuticals, Inc. acquired 100% of Nika Pharmaceuticals, Ltd., a limited liability company registered in Bulgaria with UIC: 175420503. The ownership was acquired from Dimitar SlavchevSavov who is an officer, director and majority shareholder of Nika Pharmaceuticals, Inc. and general manager of Nika Pharmaceuticals, Ltd. for the nominal value of the capital of the company, 5,000 BGN.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646624000056/0001826466-24-000056-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.